Experimental and clinical facts about degranol.
作者信息
BENKO S
出版信息
Ther Hung. 1958;6(1):15-8.
PMID:13625185
Abstract
摘要
相似文献
1
Experimental and clinical facts about degranol.
Ther Hung. 1958;6(1):15-8.
2
[Experimental and clinical experiences with degranol].
Orv Hetil. 1958 Jul 6;99(27):914-7.
3
[Clinical experiences with BCM (degranol) beta-bis-chlorethylamino-D-mannitoldichlorhydrate].
Krebsarzt. 1958 Feb;13(2):73-5.
4
[Pre- and post-operative dosage of degranol in operable cancer patients].
Magy Seb. 1959 Mar;12(1):65-8.
5
[Clinical and experimental results with BCM (beta-bis-1, 6-chloroethylamino-D-mannitol dihydrochloride)].
Magy Tud. 1957;8(1-2):119-21.
6
[Clinical experience with degranol].
Lijec Vjesn. 1961 Oct;83:1043-51.
7
[Clinical trials of a new nitrogen mustard, MX 101].
Montp Med. 1960 Nov;58:178-83.
8
[Disappearance of symptoms of granuloma fungoides after mustard mannitol (BCM) therapy].
Orv Hetil. 1957 Apr 28;98(17):442.
9
[Clinical experiences with the cytostatic agent mannitol-lost (Degranol)].
Med Klin. 1961 Aug 25;56:1459-61.
10
[Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
Arzneimittelforschung. 1958 Jun;8(6):360-1.
Zotero 插件